<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='2102-1531'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
<span>IHC - WT-1</span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">IHC - WT-1</h1>
<div class="post-text">
<p>The IHC - WT-1 (Wilms' Tumor-1) Diagnostic Test is an important tool in the world of medical
diagnostics, especially when it comes to identifying certain types of cancer. WT-1 is a protein that is
usually present in kidney cells during fetal development but is rarely found in adult kidney cells.</p>
<p>The IHC - WT-1 test utilizes a technique known as immunohistochemistry (IHC) to identify the presence
of specific proteins such as WT-1 in tissue samples. This test is particularly useful in diagnosing and
classifying certain types of kidney and ovarian cancers.</p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Test Name</th>
			<td scope="col">IHC - WT-1</td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Tissue </td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>No specific preparation is necessary before this test. As usual, patients should
maintain their regular diet and medication schedule unless advised differently by their healthcare
provider.</td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>3 days</td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>â‚¹ 2000</td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
<h2 class="test-h2 mt-3"></h2>
<p></p>

<!--section achieved-->
<?php include "../../include/iconsbox.php" ?>
<!--//section achieved-->

<h2 class="test-h2 mt-3"> Why is the IHC - WT-1 Diagnostic Test important?</h2>
<p>
The IHC - WT-1 test is crucial in diagnosing specific types of cancer, such as Wilms' tumor (a type of
kidney cancer commonly seen in children), and certain types of ovarian cancers. The results can
influence clinical decisions regarding prognosis and treatment.</p>
<h2 class="test-h2 mt-3"> Do I need to fast before this test?</h2>
<p>
No, fasting is not necessary for this test, as it involves the analysis of tissue samples, not blood.</p>
<h2 class="test-h2 mt-3"> When should this test be done?</h2>
<p>
This test is generally performed when a patient has been diagnosed with a tumor, and there is a need to
identify the primary site, particularly when a kidney or ovarian origin is suspected.</p>
<h2 class="test-h2 mt-3"> What information does this test provide?</h2>
<p>
The IHC - WT-1 test identifies the presence of the WT-1 protein in tissue samples. A positive result can
suggest that the sampled tumor originated from kidney or ovarian tissues, helping to classify the type of
cancer.</p>
<h2 class="test-h2 mt-3"> How often should this test be done?</h2>
<p>
The frequency of this test is based on the individual's clinical circumstances and should be advised by
their healthcare provider.</p>
<h2 class="test-h2 mt-3"> What are the normal values for this test?</h2>
<p>
In tissue samples, 'normal' values are not strictly applicable. The interpretation of results should be
performed by a healthcare provider in the context of the patient's overall clinical picture.</p>
<h2 class="test-h2 mt-3"> What precautions should I take before the test?</h2>
<p>

No special precautions are necessary before this test. Patients should continue with their usual diet and
medications unless instructed otherwise by their healthcare provider.</p>
<h2 class="test-h2 mt-3"> What factors could affect WT-1 levels?</h2>
<p>
WT-1 levels can be influenced by the presence and type of cancer, specifically kidney and certain types
of ovarian cancers.</p>
<h2 class="test-h2 mt-3"> What should I do if my test results are abnormal?</h2>
<p>
If your test results are abnormal, it is advisable to discuss them with an oncologist or the healthcare
provider who ordered the test. They can interpret the results in the context of your overall health
condition and guide further investigations or treatments as required.</p>
<h2 class="test-h2 mt-3"> Are there any risks associated with this test?</h2>
<p>
The risks associated with this test primarily involve the biopsy procedure used to obtain the tissue
sample. These may include discomfort, bleeding, or infection.</p>
<h2 class="test-h2 mt-3"> Can medications affect the test results?</h2>
<p>
Currently, there are no known medications that specifically influence WT-1 levels.</p>
<h2 class="test-h2 mt-3"> Is the IHC - WT-1 test used solely for diagnosing cancers?</h2>
<p>
While the primary use of the IHC - WT-1 test is in the diagnosis and classification of certain cancers, it
may also be utilized in specific clinical situations or research as determined by a healthcare provider.</p>
<h2 class="test-h2 mt-3"> What happens if the test result is positive?</h2>
<p>
A positive result for the IHC - WT-1 test indicates the presence of the WT-1 protein in the tissue sample.
This result can suggest the presence of certain types of cancers, particularly Wilms' tumor or certain
ovarian cancers. However, further interpretation should be made by a healthcare provider considering
the overall clinical context.</p>
<h2 class="test-h2 mt-3"> Are there other tests typically performed alongside this one?</h2>
<p>
Yes, the IHC - WT-1 test is often part of a larger panel of tests, including other IHC markers and possibly
genetic tests, to diagnose and classify tumors accurately.</p>
<h2 class="test-h2 mt-3"> Who performs the IHC - WT-1 test?</h2>
<p>
This test is performed by a pathologist in a laboratory setting.</p>
<h2 class="test-h2 mt-3"> Is this test recommended for both men and women?</h2>
<p>
Yes, this test can be performed on both men and women if there is a need to evaluate for certain types
of tumors. However, since WT-1 is often used in diagnosing certain ovarian cancers, it may be more
commonly used in women.</p>
<h2 class="test-h2 mt-3"> Can this test be used for conditions other than cancers?</h2>
<p>

While the primary use of the IHC - WT-1 test is in the assessment of certain cancers, it may be used in
other specific clinical situations or research as determined by a healthcare provider.</p>
<h2 class="test-h2 mt-3"> Can lifestyle changes affect the test results?</h2>
<p>
While maintaining a healthy lifestyle is always beneficial, it does not directly influence WT-1 levels,
which are primarily determined by the presence of specific cancers.</p>
<h2 class="test-h2 mt-3"> Is the IHC - WT-1 test painful?</h2>
<p>
The test itself is not painful. However, the biopsy procedure used to obtain the tissue sample can cause
some discomfort.</p>
<h2 class="test-h2 mt-3"> Can the IHC - WT-1 test predict how well I will respond to treatment?</h2>
<p>
The IHC - WT-1 test can provide useful information for the classification of certain cancers, which can
guide treatment decisions. However, individual responses to treatment involve many factors and should
be discussed with your healthcare provider.</p>
<p>In summary, the IHC - WT-1 Diagnostic Test is an essential tool in the diagnosis and management of
certain types of cancers, particularly Wilms' tumor and certain ovarian cancers. Always consult your
healthcare provider for a thorough interpretation of your test results and guidance on the next steps for
your health journey.</p>


</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>